Cabozantinib capsule specifications and current market sales price inquiry

Cabozantinib (Cabozantinib) is a multi-target tyrosine kinase inhibitor commonly used to treat solid tumors such as renal cell carcinoma, liver cancer, and thyroid cancer. In overseas markets, the original drug of cabozantinib (trade name Cabometyx or Cometriq) mainly exists in the form of capsules or tablets. Prices include 20mg 90 tablets, 60mg 30 tablets and 80mg*30 tablets. Among them, 60mgonce a day is the more common recommended dose, and the specific medication regimen needs to be determined by a professional doctor based on the patient's condition.

As of2025, cabozantinib has not yet been approved for marketing in mainland China, and patients are temporarily unable to obtain it through regular domestic hospitals. If some patients urgently need this product, they usually choose to purchase it through overseas channels, including hospital outsourcing and overseas pharmacy purchasing. Currently, there is no relevant domestic policy for cabozantinib to be included in the medical insurance catalog, so all medication costs must be borne by the patient themselves.

Multiple versions of the original cabozantinib drug have been launched overseas, including the European version, Hong Kong version, Japanese version and Turkish version. These versions have higher drug quality standards and guaranteed efficacy. In terms of price, the price of original research versions in Europe and Japan usually ranges from more than 20,000 yuan to more than 50,000 yuan. The specific price is greatly affected by specifications, channels and exchange rate fluctuations. The Hong Kong version is also favored by many Chinese patients due to its short distance and convenient transportation.

In addition to the original drug, generic versions of cabozantinib are also legally available in Laos and Bangladesh. Common specifications of these generic drugs include 20mg 90 tablets, 60mg 30 tablets, 80mg*30 tablets, covering different dosage needs. The ingredients of generic drugs are basically the same as those of the original drugs, and their efficacy is similar, but the price is more affordable, usually between 500 yuan and one to two thousand yuan. For patients with a heavy financial burden, it is a more cost-effective alternative. It is recommended that patients choose appropriate specifications according to their condition and medication cycle under the guidance of a doctor.